Brintellix (Avera McKennan Hospital)


Welcome to the PulseAid listing for the Brintellix drug offered from Avera McKennan Hospital. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Avera McKennan Hospital
NON-PROPRIETARY NAME: vortioxetine
SUBSTANCE NAME: VORTIOXETINE HYDROBROMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-06-05
END MARKETING DATE: 0000-00-00


Brintellix HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBrintellix from Avera McKennan Hospital
LABELER NAME: Avera McKennan Hospital
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/1)
START MARKETING DATE: 2015-06-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69189-0560_6ee1ed01-7b8e-43f5-9d0b-bca0e2a0b73f
PRODUCT NDC: 69189-0560
APPLICATION NUMBER: NDA204447

Other VORTIOXETINE HYDROBROMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalBrintellix
Takeda Pharmaceuticals America, Inc.Brintellix